By Michele Maatouk
Date: Thursday 29 Oct 2026
(Sharecast News) - Haleon shares tumbled on Thursday after the consumer healthcare firm cut its full-year organic revenue growth guidance, pointing to soft third-quarter cold and flu sales.
The company now expects 2026 organic revenue growth of around 2.5%, down from previous guidance of 3% to 5%.
In the three...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news